{
  "docId": "019de073-9f6d-75d9-b724-0b887fde2468",
  "docSlug": "f957aa564e21bc93d4cc30c084ec8efa",
  "documentTitle": "Aldeyra Therapeutics | Results Presentation Deck | 13 slides",
  "authorId": "aldeyra-therapeutics",
  "authorName": "Aldeyra Therapeutics",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2022-10-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 12,
  "pageCount": 13,
  "prevPage": 11,
  "nextPage": 13,
  "slideType": "comparison_table",
  "function": "analyze_data",
  "density": "dense",
  "nDataPoints": 36,
  "notes": "Forest plot showing safety outcomes; includes p-value for overall effect.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de073-9f6d-75d9-b724-0b887fde2468/12",
  "deckHref": "/decks/019de073-9f6d-75d9-b724-0b887fde2468",
  "deckJsonHref": "/decks/019de073-9f6d-75d9-b724-0b887fde2468.json",
  "deckAnchorHref": "/decks/019de073-9f6d-75d9-b724-0b887fde2468#slide-12",
  "components": [
    {
      "bbox": {
        "h": 0.7,
        "w": 0.6,
        "x": 0.2,
        "y": 0.2
      },
      "kind": "chart",
      "text": "Forest plot of adverse events",
      "attrs": null,
      "subkind": "line",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "ff6990cb-f77d-4ad1-b580-b7d371548d31",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.6,
        "x": 0.05,
        "y": 0.92
      },
      "kind": "source-note",
      "text": "CI = confidence interval. P value derived from random effect meta-analysis. ADX-2191 (methotrexate injection, USP) for intravitreal administration is an investigational drug candidate.",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "a5ebc88b-9393-4f8c-9372-c3e56882cc02",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.6,
        "x": 0.2,
        "y": 0.18
      },
      "kind": "subtitle",
      "text": "All treatment-emergent adverse events affecting at least 10% of patients in either treatment group",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "95e63be0-2e1d-4ba0-a6f2-feb378122965",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.9,
        "x": 0.02,
        "y": 0.05
      },
      "kind": "title",
      "text": "ADX-2191 Was Numerically Favorable to Routine Surgical Care for Additional Key Safety Endpoints",
      "attrs": null,
      "subkind": "action-title",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "255a365e-5944-499b-90d4-c42e8142bee5",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [
    {
      "name": "comparison_frame",
      "slug": null,
      "matchId": "0e6d76d7-f5f0-4179-bc45-083a9ec69f47",
      "evidence": "Comparison of safety endpoints between two treatment groups",
      "confidence": 0.8
    }
  ],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}